Abstract
We developed a dosimeter that measures biological damage following delivery of therapeutic beams in the form of double-strand breaks to DNA. The dosimeter contains DNA strands that are labeled on one end with biotin and on the other with fluorescein and attached to magnetic microbeads. Following irradiation, a magnet is used to separate broken from unbroken DNA strands. Then, fluorescence is utilized to measure the relative amount of broken DNA and determine the probability for double-strand break. The long-term goal for this research is to evaluate whether this type of biologically based dosimeter holds any advantages over the conventional techniques. The purpose of this work was to optimize the dosimeter fabrication and usage to enable higher precision for the long-term research goal. More specifically, the goal was to optimize the DNA dosimeter using three metrics: the response, precision, and cost per dosimeter. Six aspects of the dosimeter fabrication and usage were varied and evaluated for their effect on the metrics: (1) the type of magnetic microbeads, (2) the microbead to DNA mass ratio at attachment, (3) the type of suspension buffer used during irradiation, (4) the concentration of the DNA dosimeter during irradiation, (5) the time waited between fabrication and irradiation of the dosimeter, (6) the time waited between irradiation and read out of the response. In brief, the best results were achieved with the dosimeter when attaching 4.2 μg of DNA with 1 mg of MyOne T1 microbeads and by suspending the microbead-connected DNA strands with 200 μL of phosphate-buffered saline for irradiation. Also, better results were achieved when waiting a day after fabrication before irradiating the dosimeter and also waiting an hour after irradiation to measure the response. This manuscript is meant to serve as guide for others who would like to replicate this DNA dose measurement technique.
Keywords: DNA dosimeter, radiation biology, DNA double-strand break
1. Introduction
The improvement of radiation detectors helps to create more accurate, precise, and safer deliveries of ionizing radiation [1]. Conventional forms of radiation measurements are made with dosimeters that use chemical and physical approaches to determine the energy deposition by ionizing radiation, and afterwards, correction factors can be required to calculate actual deposition of radiation energy for a patient such as the quality conversion factor and absorbed-dose to water calibration factor [2], yet none of these detectors directly measure biological damage. A DNA dosimeter could provide a more biologically relevant measure of radiation damage following therapeutic delivery by attempting to link radiation dose with a meaningful biological metric.
Radiation induced DNA damage falls into three basic categories: base damage [3–6], single-strand break (SSB) [7–10], and double-strand break (DSB) [11–16]. DSB are difficult to repair and highly toxic compared to base damage and SSB. DSB are generally accepted to be one of the dominant factors for radiation-induced cell killing and could be used as a form of measurement [17]. The functionality of the DNA dosimeter is provided through the attachment of a fluorescent marker, fluorescein amidite (6FAM), to 4 kilo base-pair (kbp) DNA strand, which is attached to magnetic microbeads (Fig. 1a). After irradiation of the dosimeter (Fig. 2a), a DSB would cause fluorescent ends to fragment and then disperse into the supernatant (see Fig. 1c). Then, broken fluorescent DNA fragments can be separated from the remaining microbeads with unbroken DNA using a magnet, and analysis of fluorescence readings is used to the calculate the probability of DSB (PDSB). PDSB is defined as the ratio of the fluorescence intensity of the supernatant to the fluorescence intensity of the whole dosimeter. This method of detection has been previously shown to successfully measure DNA DSBs as a function of dose [18].
Figure 1.

(a) The DNA dosimeter consisting of four basic components: magnetic microbeads, 4 kbp double-stranded DNA, biotin, and 6-FAM. (b) Irradiation of the dosimeter. (c) If DSB occurs, the fluorescein becomes free and is no longer attached to the microbeads, then a magnet can be used to separate the broken pieces of DNA from the intact ones.
Figure 2.

Separating the supernatant and microbeads following irradiation of the DNA dosimeter by placing the irradiated DNA dosimeter against a magnet, then waiting few minutes before extracting the supernatant.
It is important for dosimeter measurements to be precise [19] as they can affect interpreted machine dose outputs and therefore also dose delivered to patients. Our goal for the level of precision required for the dosimeter was 1%, which is similar to what can be obtained from other radiation dosimeters that come in batches. We initially faced problems consistently reaching this level of precision. For this reason, the basic aim of this work was to revisit selected steps of the DNA dosimeter fabrication and how we measure its response to improve the reproducibility. There were six main areas of focus: (1) the type of microbeads we attach to the DNA strands, (2) the microbeads to PCR mass ratio during the attachment process, (3) the type of suspension buffer for irradiation of the dosimeter, (4) the concentration of the DNA dosimeter, (5) the waiting time between the fabrication and irradiation of the dosimeter, and (6) the waiting time between irradiation and separation of supernatant and microbeads to measure the response. The optimization metrics used in this study were: the coefficient of variation (CoV) to measure the precision of the response, DNA dosimeter response (PDSB), and cost. The goal of each experiment was to minimize the CoV and cost, while maximizing the response of the DNA dosimeter.
The ultimate goal of this work is to make biologically relevant radiation measurements. Future work will benchmark the DNA dosimeter response against cell survival curves. More specifically, the metric for comparison will be relative biological effectiveness. These types of experiments will be critical in determining the relevance of the DNA dosimeter response. However, optimization experiments such as those performed in this manuscript, are crucial to enable more accurate and cost-effective biological measurements.
2. Methods
A. Dosimeter Fabrication
To create the DNA dosimeter, 4kbp DNA was synthesized using polymerase chain reaction (PCR) with a combination of oligonucleotides, fluorescein amidite (6FAM), and biotin. The sequence itself was a random one from the PRS-316 DNA template. The AT:CG content of the synthesized 4kbp DNA was 0.54:0.46. The PCR reaction relies on thermal cycling to alternate between heating and cooling the samples through a defined series of temperature steps. Table 1 summarizes the recipe used to create 400 μL of PCR product and Table 2 shows the thermal cycle steps used to run the PCR reaction which consists of 35 cycles. The net product of this reaction is 4 kbp double-strands DNA, which is labeled on one end with biotin and on the other with FAM.
Table 1.
The required volume and concentration of materials to create 400 μL of PCR product. U: unit of enzyme activity.
| Material | Volume (μL) |
|---|---|
| Deionized water | 334.4 |
| Accu PCR buffer (I) | 40 |
| Biotin-pRS316 4kb 5 ′ (10 pmol/μL) | 8 |
| FAM-pRS316 3 ′(10 pmol/μL) | 8 |
| PRS 316 (5ng/μL) | 8 |
| Accuprime taq polymerase high fidelity (5U/μL) | 1.6 |
Table 2.
The thermal cycle used to run the PCR reaction. The denaturation, Annealing, and elongation steps were repeated 35 times. ∞ denotes a temporary store of the PCR product in the cycler at 12 °C.
| Temperature (°C) | Time on hold (s) | |
|---|---|---|
| Initialization step | 94 | 15 |
| Denaturation step | 94 | 15 |
| Annealing step | 55 | 15 |
| Elongation step | 68 | 240 |
| Final elongation step | 68 | 300 |
| Final hold step – short term | 12 | ∞ |
The DNA strands were then attached to magnetic microbeads coated in streptavidin using the manufacturer-recommended immobilization procedure (Thermo Fisher Scientific, Waltham, MA). The amount of PCR product that attaches to the magnetic microbeads significantly decreases as the DNA double strands length exceeds 2 kbp for common binding buffers. Thermo Fisher Scientific has the dynabeads kilobase binder kit binding buffer that was specifically designed to attach longer DNA strands. The following steps were used to attach the PCR product with 1 mg of magnetic microbeads:
200 μL of washing buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, and 2.0 M NaCl) was added gently to 1 mg of magnetic microbeads and placed inside a micro centrifuge tube to be washed by placing the tube against a magnet, then waiting few minutes before extracting and discarding the supernatant.
The washed magnetic microbeads were resuspended in 200 μL of binding buffer.
100 μL of distilled water and a specific mass of PCR product (see Section E) were added to the suspended magnetic microbeads inside the microfuge tube.
The mixture was incubated at room temperature for 3 hours on a roller to keep the microbeads in suspension. During this, the mixture was covered with aluminum foil to block the room light.
The microbead-connected DNA strands were washed twice with 500 μL of washing buffer, then once with 500 μL of elution buffer (10 mM Tris HCl, pH 7.5).
The microbead-connected DNA strands were resuspended and stored in 200 μL of washing buffer refrigerated in dark.
To prepare the dosimeter for irradiation experiments, the storage washing buffer was first discarded, then we resuspended the microbead-connected DNA strands with a specific volume of a buffer (see Section E) and placed in a microtube for irradiation. The irradiated DNA dosimeters had a volume of 50 μL of these suspended microbead-connected DNA double strands.
B. Irradiation setups
Irradiation has been performed by 6 MV photons from a Varian linear accelerator. These occurred in one of two phantom setups: a water-equivalent plastic phantom or a water tank. The plastic phantom (9.3×9.3×10 cm3) was set up on a tray attached to the linear accelerator head at 57.5 cm source to surface distance (SSD) and the samples were irradiated at 5 cm depth. The water tank (53×64×53 cm3) was set up at 60 cm SSD and the samples were irradiated at a 5 cm depth. The majority of the irradiations occurred in the plastic phantom, due to its ease of setup, but some were performed in the water tank when one was already setup that day for other experiments. For both plastic and water setups, the doses were set based on monitor unit hand calculations from our institutional databook and were corrected based on the daily variation of the output of the linac. This daily variation was determined by comparing measurements with a calibrated 0.3 cm3 Semiflex 31013 ionization chamber (PTW, Freiburg, Germany) in our monthly machine output setup to the baselines acquired at the last annual TG-51 calibration. No correction was performed as this would not affect both the dose deposition and CoV interpreted from the dosimeter readings regardless of the setup we used.
C. DSB Measurement
Following irradiation of the DNA dosimeter, we used a DynaMag 2 magnet (Thermo Fisher Scientific, Waltham, MA) to separate broken from unbroken DNA. The magnetic field (3500–3700 Gauss) pulls the magnetic microbeads against the side of the tube (Fig. 2). Then, the supernatant (S), which represents the fluorescein ends that became free from microbeads, was extracted with a pipette and placed in another microtube. The remaining unbroken DNA was resuspended with 50 μL of phosphate buffered saline (PBS) in the original microtube and its fluorescence signal is referred to here as microbeads (B). Then, we placed both supernatant and microbeads in a reader microplate, and we read the fluorescence signal for each using a Synergy 2 fluorescence reader (BioTek, Winooski, VT). PDSB was calculated with the following equation.
| Equation (1) |
The variable S represents the fluorescence of the supernatant (DNA with DSB), B represents the microbeads (DNA without DSB), and BG was the pure PBS fluorescence intensity (related to the background signal).
D. Optimization Metrics
Three metrics were chosen to be used in the optimization process: precision, dosimeter response, and cost of the DNA dosimeter. CoV is the mathematical metric we utilized to quantify precision of response for the irradiated DNA dosimeters. Each experiment here was repeated at least three total times. For each experiment repeat, the values varied slightly, but the conclusion for parameters leading to the optimal metric remained the same. The data values (average and CoV) presented here are for five dosimeter readings from the final, most-controlled experiment. Calculating metrics from one experiment avoided the inflation of CoV from inter-batch variations. CoV is calculated by dividing the standard deviation of PDSB over the mean value [15–17]. A lower value of CoV indicates less variation in response, which means a more precise response of the DNA dosimeter. PDSB was the metric we used to quantify the dosimeter response. A higher value of PDSB not only meant a higher percentage of DSB, but also a higher signal-to-noise ratio.
The current dose range of the dosimeter only enables precise measurements (CoV ~1%) for doses around 50 Gy and above. For example, at 5 and 10 Gy the CoV is typically around 14% and 7%, respectively [18]. Performing experiments with this large CoV would make it difficult to assess whether our interventions are improving the system or not. For this reason, we performed the optimization experiments with doses at 50 Gy and above, where we obtain our most precise response.
Variations in the fabrication techniques for many experiments not only affected the precision and response but also the cost of the DNA dosimeter. For this reason, dosimeter cost was considered as a part of the optimization metrics we used in this project. We created a spreadsheet containing the materials, volumes, and cost of each material used in experiments. This spreadsheet was used to calculate the estimated cost per dosimeter for each condition we changed in the optimization experiments.
We performed some preliminary evaluation for the effect of temperature on DSB stability. We saw an increase in response with increasing temperature, but no reduction of CoV. This can explored in the future work but it is beyond the scope of this work.
E. Refinement of the response, precision, and cost of the DNA dosimeter
Type of magnetic microbeads
We attached the PCR product to two different types of microbeads: Dynabeads M-280 and MyOne T1 (Thermo Fisher Scientific, Waltham, MA). Both types differ in both the diameter (2.8 and 1μm for M-280 and T1, respectively) and the binding efficiency to PCR product. The purpose here was to investigate which type of microbeads enhances the response, CoV, and cost of the DNA dosimeter. A Varian Clinac 23EX was used to deliver dose levels of 50, 100, and 200 Gy to the DNA dosimeters using the water-equivalent plastic phantom irradiation setup.
Microbead to PCR mass attachment ratio
In Step 3 of the dosimeter fabrication, a specific mass of the PCR product was added to 1 mg of microbeads then incubated for few hours to let the DNA double-strands attach to the microbeads. The purpose here was to attach different masses of PCR product (1.1, 2.1, 4.2, 8.4, and 16.8 μg) to 1 mg of microbeads to investigate the appropriate amount of PCR needed to optimize the response, CoV, and cost of the DNA dosimeter. The masses of PCR were calculated by multiplying the concentration of the PCR product by the volume we used in each experiment, and the concentration of PCR was estimated by running gel electrophoresis for different dilutions of the PCR product to find the concentration. A Varian Clinac 23EX was used to deliver 50 Gy to the DNA dosimeters using the water-equivalent plastic phantom irradiation setup.
Type of suspension buffer for irradiation
In Step 7 of the dosimeter fabrication, we suspended the microbead-connected DNA strands with a buffer for irradiation. The purpose here was to test if changing the irradiation buffer will have an effect on the response, precision, and cost of the DNA dosimeter. We suspended the microbead-connected DNA strands with three types of buffer for irradiation: elution buffer (10 mM Tris HCl, pH 7.5), washing buffer (10 mM Tris HCl, pH 7.5, 1 mM EDTA, and 2.0 M NaCl), and PBS (10mM Na2HPO4, 2.7mM KCl, 137mM NaCl, and 1.76mM KH2PO4, pH 7.4). A Varian Clinac 23EX was used to deliver dose levels of 50, 100, and 200 Gy to the DNA dosimeters using the water-equivalent plastic phantom irradiation setup.
Irradiation concentration of the DNA dosimeter
In Step 7 of the dosimeter fabrication, the same volume of microbead-connected DNA strands was suspended with different volumes of the buffer (100, 200, and 400 μL) to create different concentrations of the dosimeter. This experiment was performed after we decided what type of suspension buffer we used for irradiation (type of suspension buffer for irradiation experiment). The purpose here was to create different concentrations of the DNA dosimeter to test which one optimized the response, CoV, and cost of the DNA dosimeter. A Varian Clinac 23EX was used to deliver 50 Gy to the DNA dosimeters using the water tank irradiation setup.
F. Optimizing the time interval between fabrication, irradiation, and separating the supernatant and microbeads
Time between fabrication and irradiation of the DNA dosimeter
The purpose here was to test if the effect of the waiting time between the fabrication and irradiation of the DNA dosimeter on both the response and precision of the DNA dosimeter. After fabricating a batch of the DNA dosimeter, we tested both waiting for an hour and waiting for a day before irradiating the DNA dosimeter with a Varian Clinac 23EX to 50 and 100 Gy using the water-equivalent plastic phantom irradiation setup. This experiment had no impact on the cost of dosimeter.
Time between irradiation and separation of supernatant and microbeads
The time we needed to wait following irradiation of the dosimeter to separate the supernatant and microbeads was investigated here to test the effect on both response and precision of the DNA dosimeter. One batch of the DNA dosimeter was fabricated and a Varian Novalis Tx was used to deliver 50, 100, and 150 Gy to two sets of the same batch using the water tank irradiation setup. For the first set, we separated the supernatant and microbeads directly following irradiation, while for the second one, we waited an hour before the separation. This experiment had no impact on the cost of dosimeter.
3. Results
Type of magnetic microbeads
Table 3 shows the DNA dosimeter response and CoV for different dose levels when attached to two different types of microbeads (the cost for both types of microbead is equal). Both the response and CoV of the DNA dosimeter improved when the MyOne T1 microbeads are utilized.
Table 3.
The DNA dosimeter response (PDSB) and CoV when attached to different types of microbeads.
| Dynabeads M-280 | MyOne T1 beads | |||
|---|---|---|---|---|
| Dose [Gy] | PDSB | CoV | PDSB | CoV |
| 50 | 0.010 | 0.43 | 0.050 | 0.045 |
| 100 | 0.016 | 0.07 | 0.097 | 0.010 |
| 150 | 0.030 | 0.04 | 0.156 | 0.026 |
Microbead to PCR mass attachment ratio
Table 4 shows the DNA dosimeter response, CoV, and cost when attached to different PCR masses during fabrication then irradiated to 50 Gy. The lowest CoV (highest precision of response) was achieved by attaching 4.2 μg of PCR with 1 mg of microbeads.
Table 4.
The DNA dosimeter response (PDSB), CoV, and cost per dosimeter for different attached masses of PCR to the same amount of microbeads.
| PCR mass (μg) | PDSB | CoV | Cost ($) |
|---|---|---|---|
| 1.1 | 0.047 | 0.15 | 5.85 |
| 2.1 | 0.059 | 0.039 | 6.07 |
| 4.2 | 0.054 | 0.028 | 6.5 |
| 8.4 | 0.071 | 0.12 | 7.39 |
| 16.8 | 0.058 | 0.042 | 9.16 |
Type of suspension buffer for irradiation
Table 5 shows the DNA dosimeter response for different dose levels when suspended with different types of buffer for irradiation. The table shows an enhancement in both the dosimeter response and CoV when suspended with PBS. The cost of the DNA dosimeter for all suspensions was very similar. Figure 3 shows a graphical representation for table 5.
Table 5.
The DNA dosimeter response (PDSB) and CoV when suspended with different types of buffer for irradiation.
| Elution buffer | Washing buffer | PBS | ||||
|---|---|---|---|---|---|---|
| Dose [Gy] | PDSB | CoV | PDSB | CoV | PDSB | CoV |
| 50 | 0.017 | 0.23 | 0.012 | 0.27 | 0.048 | 0.14 |
| 100 | 0.021 | 0.08 | 0.039 | 0.030 | 0.052 | 0.023 |
| 200 | 0.025 | 0.051 | 0.058 | 0.028 | 0.119 | 0.017 |
Figure3:

The response (PDSB) and CoV for the DNA dosimeter when suspended with different types of buffer for irradiation. EB: elution buffer, WB: washing buffer.
Irradiation concentration of the DNA dosimeter
Table 6 shows the DNA dosimeter response, CoV, and cost per dosimeter for different concentrations of dosimeters when irradiated to 50 Gy. The CoV was similar for resuspensions with 100 and 200 μL of PBS (0.011 and 0.012, respectively) but the response was higher for the 100 μL suspension (the most concentrated DNA dosimeter).
Table 6.
The DNA dosimeter response (PDSB), CoV, and cost per dosimeter for different concentrations of the DNA dosimeter created by suspending the same amount of microbead-connected DNA strands with different volumes of PBS.
|
100 μL of PBS Cost: $13 |
200 μL of PBS Cost: $6.5 |
400 μL of PBS Cost: $3.25 |
|||
|---|---|---|---|---|---|
| PDSB | CoV | PDSB | CoV | PDSB | CoV |
| 0.191 | 0.011 | 0.116 | 0.012 | 0.088 | 0.043 |
Time between fabrication and irradiation of the DNA dosimeter
Table 7 shows the effect of the waiting time between the DNA dosimeter fabrication and irradiation on both the response and CoV for different dose levels. The results indicate that waiting for one day significantly enhanced the CoV changing from 0.16 and 0.13 to 0.045 and 0.010 for 50 and 100 Gy, respectively.
Table 7.
The DNA dosimeter response (PDSB) and CoV when irradiated after an hour and a day after fabrication.
| 1 hour | 1 day | |||
|---|---|---|---|---|
| Dose [Gy] | PDSB | CoV | PDSB | CoV |
| 50 | 0.060 | 0.16 | 0.058 | 0.045 |
| 100 | 0.089 | 0.13 | 0.093 | 0.010 |
Time between irradiation and separation of supernatant and microbeads
Table 8 shows the effect of the waiting time between the DNA dosimeter irradiation and separating the supernatant and microbeads on both the response and CoV for different dose levels. The results indicate that both the response and CoV improved by waiting an hour before we performed the separation.
Table 8.
The DNA dosimeter response (PDSB) and CoV when the response is measured without waiting and one hour later to separate the supernatant and microbeads following irradiation.
| No waiting | 1 hour | |||
|---|---|---|---|---|
| Dose [Gy] | PDSB | CoV | PDSB | CoV |
| 50 | 0.051 | 0.067 | 0.132 | 0.017 |
| 100 | 0.092 | 0.080 | 0.223 | 0.013 |
| 150 | 0.178 | 0.048 | 0.318 | 0.021 |
4. Discussion
The key driving factor of optimizing the DNA dosimeter was to enhance the response and decrease the CoV. Some of the experiments naturally affected the cost. For the microbead to PCR mass attachment ratio experiment, attaching 4.2 μg of PCR product with 1 mg of microbeads produced the lowest CoV and a less expensive DNA dosimeter than if we used higher masses of PCR. For the same experiment, we were able to fabricate a less expensive dosimeter but the compromise here was a lower response and a higher CoV.
For concentration of the DNA dosimeter experiment, the CoV was similar for both 100 and 200 μL PBS suspensions so the key to choosing between these became the cost, the 200 μL PBS suspension produced twice the number of DNA dosimeters with the same total cost and CoV as the 100 μL PBS suspension. Thus, a 200 μL PBS suspension was utilized for the DNA dosimeter. We optimized the cost of the DNA dosimeter by finding the cheapest formula which created a 0.01 CoV for doses around 50 Gy. The cost of the DNA dosimeter is currently at $6.5 per 50 μL dosimeter.
Using PBS enhanced the response of the DNA dosimeter for all dose levels compared to the other buffers we tested. Also, using PBS to suspend the DNA dosimeter samples not only improved the response, but also had a biological advantage as its ions concentration and osmolarity matches the internal environment of our body (isotonic for mammalian cells) [23]. This match between the PBS and human bodies can be considered as an advantage for the DNA dosimeter.
The effect of the waiting time between fabrication, irradiation, and separation was investigated because of the high CoV we got for some experiments while using the same dosimeter fabrication formula. Finding the appropriate waiting time which produced a lower CoV also helped us to keep a consistency between experiments and excluded a factor that could change the precision of the DNA dosimeter response. We tried many other time periods before this set but the experiments were not systematically controlled well. We noted general trends demonstrating the importance of waiting around a day after dosimeter fabrication before usage and also waiting at least an hour after irradiation before separation. This is why we chose to focus on these time periods for the controlled experiments here.
5. Conclusion
The DNA dosimeter optimization process consisted of testing a number of variables through different experiments. For each variable experiment, we investigated the best condition to produce a higher response, a lower CoV, and a cheaper cost. The best results were achieved with the dosimeter when attaching 4.2 μg of DNA with 1 mg of MyOne T1 microbeads and by suspending the microbead-connected DNA strands with 200 μL of phosphate-buffered saline for irradiation. Beyond this, it was preferable to wait a day after fabrication to irradiate the DNA dosimeter and to wait an hour after irradiation before we separate the supernatant and microbeads to read the response. This generally allowed us to produce a CoV on the order of 0.01 reproducibly with a fabrication cost of $6.5 for doses around 50 Gy.
Acknowledgments
This research was supported by grants from the Cancer Prevention Research Institute of Texas (RP140105 and RP170345), the National Institute of Health’s Institutional Research and Academic Development Awards (K12 GM111726), and the President’s Translational and Entrepreneurial Research Fund from UT Health San Antonio.
References
- [1].Seco J, Clasie B, and Partridge M (2014). “Review on the characteristics of radiation detectors for dosimetry and imaging”. Physics in Medicine and Biology 59(20), R303. [DOI] [PubMed] [Google Scholar]
- [2].Almond PR, Biggs PJ, Coursey BM, et al. (1999). “AAPM’s TG-51 protocol for clinical reference dosimetry of high-energy photon and electron beams”. Medical Physics 26:1847–1870. [DOI] [PubMed] [Google Scholar]
- [3].Krokan HE and Bjoras M (2013). “Base Excision Repair”. Cold Spring Harbor Perspectives in Biology 5:a012583. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Fromme JC and Verdine GL (2004). “Base Excision Repair”. Advances in Protein Chemistry 69:1–41. [DOI] [PubMed] [Google Scholar]
- [5].Sheila SD, Valerie LO, and Sucharita K (2007). “Base-excision repair of oxidative DNA damage”. Nature 447:941–950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Klungland A, Matthias H, Gunz D, Constantinou A, Clarkson SG, Doetsch PW, Bolton PH, Wood RD, and Lindahl T (1999). “Base Excision Repair of Oxidative DNA Damage Activated by XPG Protein”. Molecular Cell 3(1):33–42. [DOI] [PubMed] [Google Scholar]
- [7].Peggy Olive L (1998). “The Role of DNA Single- and Double-Strand Breaks in Cell Killing by Ionizing Radiation”. Radiation Research 150(5s): S42–S51. [PubMed] [Google Scholar]
- [8].Caldecott KW (2008). “Single-strand break repair and genetic disease”. Nature Reviews Genetics 9:619–631. [DOI] [PubMed] [Google Scholar]
- [9].Hutchinson F (1985). “Chemical changes induced in DNA by ionizing radiation”. Progress in Nucleic Acid Research and Molecular Biology 32:115–154. [DOI] [PubMed] [Google Scholar]
- [10].Whitehouse CJ et al. (2001). “XRCC1 Stimulates Human Polynucleotide Kinase Activity at Damaged DNA Termini and Accelerates DNA Single-Strand Break Repair”. Cell 104(1):107–117. [DOI] [PubMed] [Google Scholar]
- [11].Chu G (1997). “Double Strand Break Repair”. The Journal of Biological Chemistry 272:24097–24100. [DOI] [PubMed] [Google Scholar]
- [12].Szostak JW, Orr-Weaver TL, Rothstein RJ, and Stahl FW (1983). “The double-strand-break repair model for recombination”. Cell 33(1):25–35. [DOI] [PubMed] [Google Scholar]
- [13].Von Sonntag C, Hagen U, Schon-Bopp A, and Schulte-Frohlinde D (1981). “Radiation-induced strand breaks in DNA: chemical and enzymatic analysis of end groups and mechanistic aspects”. Advances in Radiation Biology 9:109–142. [Google Scholar]
- [14].Ward JF (1989). “The Yield of DNA Double-strand Breaks Produced Intracellularly by Ionizing Radiation: A Review”. International Journal of Radiation Biology 57 (6):1141–1150. [DOI] [PubMed] [Google Scholar]
- [15].Helleday T, Lo J, van Gent DC, and Engelward BP (2007). “DNA double-strand break repair: From mechanistic understanding to cancer treatment”. DNA Repair 6 (7):923–935. [DOI] [PubMed] [Google Scholar]
- [16].Jackson SP (2002). “Sensing and repairing DNA double-strand breaks”. Carcinogenesis 23(5):687–696. [DOI] [PubMed] [Google Scholar]
- [17].Chen W, Blazek E, Rosenberg I (1995). “The relaxation of supercoiled DNA molecules as a biophysical dosimeter for ionizing radiations: a feasibility study”. Medical Physics 22(9): 1369–1375. [DOI] [PubMed] [Google Scholar]
- [18].Obeidat M, McConnell K, Li X, Bui B, Stathakis S, Papanikolaou N, Rasmussen K, Ha CS, Lee SE, and Kirby N (2018). “DNA double-strand breaks as a method of radiation measurements for therapeutic beams”. Medical Physics. 45(7):3460–3465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19].Attix FH (1986). “Introduction to Radiological Physics and Radiation Dosimetry”. 1:277–291. [Google Scholar]
- [20].Reed GF, Lynn F, and Meade BD (2002). “Use of Coefficient of Variation in Assessing Variability of Quantitative Assays”. Clinical and Vaccine Immunology 9(6):1235–1239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [21].McKay AT (1932). “Distribution of the Coefficient of Variation and the Extended “t” Distribution”. Journal of the Royal Statistical Society 95(4):695–698. [Google Scholar]
- [22].Faber DS and Korn H. (1991). “Applicability of the coefficient of variation method for analyzing synaptic plasticity”. Biophysical Journal 60(5):1288–1294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Blomberg B, Bernard C, and Du Pasuier L (1980). “In vitro evidence for T-B lymphocyte collaboration in the clawed toad, Xenopus”. European Journal of Immunology 10(11): 869–876. [DOI] [PubMed] [Google Scholar]
